This conference has been withdrawn from the 2020 conference schedule
As you are aware, coronavirus is having a global impact and the World Health Organization and the Centers for Disease Control have instituted recommendations that include social distancing and cancelling conferences and large gatherings. Since safety of our attendees is always GRC's highest priority, the GRC Board of Trustees has decided to withdraw this conference and it will be rescheduled for 2022. This decision was made out of an abundance of caution and to alleviate the concerns of our conference communities that are scheduled to meet in this timeframe.
The critical importance of myelin for proper nervous system function is underscored by the devastating symptoms in diseases in which it is disrupted, including multiple sclerosis, leukodystrophies, and peripheral neuropathies that affect millions of individuals worldwide. It is also becoming ever clearer that myelination represents a novel mechanism modulating neural plasticity, and myelinating glia represent a major resource for the development of novel therapeutics to treat diseases of the nervous system and to promote repair following trauma.
The 2020 Myelin GRC will be held in conjunction with the critically important Myelin Gordon Research Seminar (GRS), which focuses on trainees in the field. The goal of these meetings is to provide an active forum for exchange of results in the rapidly advancing field of myelin biology in health and disease. The 2020 Myelin GRC will bring together basic scientists at all career stages as well as translational and clinical investigators to explore and highlight the most recent and important advances in myelin biology and medicine. The scientific program was designed to highlight new discoveries in all aspects of myelin biology, from cell biology and genetics to imaging to remyelination in humans.